More than 38,000 campus cases have been reported in the past two weeks
Mortality Down for Cancer Patients With Medicaid Expansion
Mortality reduced for patients with newly diagnosed breast, colorectal, lung cancers, mediated by earlier stage of diagnosis
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 2 to 6, 2020. This …
Global Burden High for Musculoskeletal Disorders
From 1990, slight decrease seen in age-standardized prevalence, disability-adjusted life year rates
Gun Violence Curriculum Benefits Surgical Trainees
Curriculum covers technical, nontechnical skills necessary to care for gun violence victims
Regulators Discuss Approval of New Alzheimer Disease Drug
Aducanumab does not cure or reverse Alzheimer disease; high dose may slow mental decline
Unhealthy Drinking Habits Seen With Some Psychiatric Disorders
People with depression, anxiety disorder, or bulimia more likely to exceed daily, weekly alcohol limits
Restricting Symptoms at the End of Life Decreasing
Decreases seen for difficulty sleeping; chest pain or tightness; shortness of breath; cold or flu symptoms; and nausea, vomiting, or diarrhea
The importance of assessing blood tumour burden in cutaneous T-cell lymphoma.
Mycosis fungoides (MF) and Sézary syndrome (SS) are the best studied subtypes of cutaneous T-cell lymphoma, and the level of blood tumour burden in patients is important for diagnosis, disease …
Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic AhR modulating agent (TAMA).
Tapinarof, a novel, first-in-class small-molecule topical therapeutic aryl hydrocarbon receptor (AhR) modulating agent (TAMA), is in clinical development for the treatment of psoriasis and atopic dermatitis. The efficacy of tapinarof …